VivoSim Labs VIVS
NASDAQ VIVS
$0.16 +0.00 (+1.34%)
As of: Oct 19, 2026 · 3:56 PM EDT

VivoSim Labs (VIVS) Sale and Maturity of Investments (2022 - 2025)

Updated

Analysis

VivoSim Labs (VIVS) Sale and Maturity of Investments (2022 - 2025) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Investments Sold (Qtr)
1 Iqvia Holdings 44.17 Bn 35.87 Bn 1.44 Bn -
2 Medpace Holdings 17.45 Bn 15.51 Bn 201.64 Mn -
3 Charles River Laboratories International 14.37 Bn 13.56 Bn 363.37 Mn 8.14 Mn
4 Icon 13.16 Bn 10.27 Bn 479.29 Mn 4.48 Mn
5 Fortrea Holdings 2.12 Bn 1.50 Bn 139.20 Mn -
6 Ginkgo Bioworks Holdings 625.60 Mn -136.48 Mn 18.44 Mn 57.99 Mn
7 Evotec SE 506.10 Mn -1.10 Bn - -
8 Champions Oncology 65.60 Mn 40.68 Mn 7.70 Mn -
9 MindWalk Holdings 61.22 Mn 24.88 Mn 1.61 Mn -
10 VivoSim Labs 832,550.47 -16.89 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2025 500,000.00
Sep 30, 2024 1.00 Mn
Jun 30, 2024 1.50 Mn
Mar 31, 2024 1.00 Mn
Dec 31, 2023 2.00 Mn
Sep 30, 2023 3.00 Mn
Jun 30, 2023 5.00 Mn
Mar 31, 2023 384,000.00
Dec 31, 2022 10.00 Mn
API Access

VivoSim Labs Sale and Maturity of Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=sale-and-maturity-of-investments&ticker=VIVS&period=max&api_key=YOUR_API_KEY